A new cancer treatment more potent than the best-selling cancer drug taxol is
working well in human trials. Epothilone, which comes from soil-dwelling
organisms called myxobacteria, stops cancer cells dividing as taxol does. When a
cell splits in two, elastic protein threads draw the chromosomes apart. But
epothilone binds to these “tubulins” and halts a tumour’s runaway cell division.
“Epothilone stops the chromosomes from being pulled apart,” says Herbie Newell
of the Newcastle University Cancer Research Unit.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Physics
The 50-year quest to create a quantum spin liquid may finally be over
Features
Technology
Backlash builds over NHS plan to hide source code from AI hacking risk
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
Hantavirus: Where has the deadly cruise ship outbreak come from?
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
Woman in cancer remission without treatment in highly unusual case
News
Popular articles
Trending New Scientist articles
1
Man destined to get Alzheimer’s saved by accidental heat therapy
2
Woman in cancer remission without treatment in highly unusual case
3
A lost ancient script reveals how writing as we know it really began
4
Hantavirus: Where has the deadly cruise ship outbreak come from?
5
The 50-year quest to create a quantum spin liquid may finally be over
6
We have figured out a new way to send messages into the past
7
Exercise helps fight cancer – and we may finally know why
8
Honey has been used as medicine for centuries – does it really work?
9
Is consciousness more fundamental to reality than quantum physics?
10
Why the keto diet could be a revolutionary way to treat mental illness
